Ergoteles’s Atea Pharmaceuticals AVIR Stock Holding History

Ergoteles’s Portfolio AVIR Stock Details AVIR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$169K	Sell
2022 Q4	$270K	Buy
2021 Q2	–	Sell
2021 Q1	$3.11M	Buy